ST-segment elevation myocardial infarction: are women being discriminated?

نویسندگان

چکیده

Abstract Background Although outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary interventions (PCI) have improved, a gender disparity exists, women showing higher mortality. Objectives To assess differences presentation, management and in-hospital, at 30-days, 6-months 1-year after STEMI Methods We collected data from 809 consecutive treated PCI compared the females versus males. Results Women were older than man (69,1±14,6 vs. 58,5±12,7 years; p<0.001) prevalence of age over 75 years (36.7% 11.7%; p<0.001), diabetes (30,6% 18,5%; p=0.001), hypertension (60.5% 45.9%; chronic kidney disease (3.4% 0.6%; p=0.010) acute ischemic stroke (6.8% 3.0%; p=0.021). At had more atypical symptoms, less chest pain (90.3% 95.6%; p=0.014) greater clinical severity (cardiogenic shock (10.7% 5.4%; p=0.011). There no symptom-first medical contact me (95.0 min 80.5 min; p=0.215); however, longer time until reperfusion (264.0 212.5 p=0.001) likely to receive optimal therapy (aspirin-93.1% 99.2%; p<0.001; P2Y12 inhibitors 91.9% 98.2%; beta-blockers-90.8% 95.1%; p=0.032; ACEIs- 88.1% 94.8%; p=0.003). In-hospital mortality (9.6% 3.5%; 30-days (11.3% 4.0%; (14.1% 4.7%; (16.4% 6.3%; was significantly women. The multivariate analysis identified (HR=4.25; 95% CI [1.67–10.77]; p=0.002), Killip class II (HR=8.80; [2.72–28.41]; III (HR=5.88; [0.99–34.80]; p=0.051) IV (HR=9.60; [1.86–48.59]; p=0.007), injury (HR=2.47; [1.00–6.13]; days hospitalization (HR=1.04; [1.01–1.08]; p=0.030) but not female (HR=0.83; [0.33–2.10]; p=0.690) as independent prognostic factors Conclusions Compared men, rates. Our results suggest that this is due itself, worse risk profile, related system delays minor probability receiving recommended therapy. Efforts should be made reduce these differences. FUNDunding Acknowledgement Type funding sources: None.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Anticoagulation for ST-segment elevation myocardial infarction.

Adjunctive anticoagulant therapy reduces the risk of recurrent infarction and death in patients with STsegment elevation myocardial infarction (STEMI) receiving fibrinolytic therapy.1–5 Unfractionated heparin (UFH), the first anticoagulant evaluated for this indication,1 continues to be used because of its predominantly nonrenal clearance, short half-life, reversibility, and the familiarity of ...

متن کامل

False Positive ST-Segment Elevation Myocardial Infarction

Acute ST-segment elevation myocardial infarction (STEMI) is a serious disease in clinical practice. The rapid and accurate diagnosis of this critical illness can lead to prompt reperfusion, and it enables the reduction of cardiac ischemic damage and results in improved subsequent outcomes. The shorter the time to reperfusion, the greater the benefits. The American College of Cardiology/American...

متن کامل

ST-Segment Elevation in Acute Myocardial Infarction

Four hundred and four patients who were admitted to the hospital with their first myocardial infarction within 24 hours of the onset of symptoms were studied. In 315 patients the ECG findings in 12 standards leads (I, II, aVF, aVR, aVL, V,-V6) showed the infarction to be in the anterior wall, the inferior wall, or in multiple areas. The patients in each of these three categories were further su...

متن کامل

Imaging of Myocardial Inflammation Post ST-Segment Elevation Myocardial Infarction

The treatment of myocardial infarction (MI) has focused heavily on early reperfusion of the infarct-related artery. However, the inflammatory processes in the infarct that occur shortly after MI and govern wound healing in the heart have not been targeted therapeutically. Perhaps this has resulted from our inability to visualize these processes. In contrast to coronary angiography, which has cl...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Heart Journal

سال: 2021

ISSN: ['2634-3916']

DOI: https://doi.org/10.1093/eurheartj/ehab724.2789